Biotech News

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Corporation (TWST)Twist Bioscience Corporation2026-06-25 13:46 ESTCompany update

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 5, 2026-- As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of

Open original release

Related news

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Present at Upcoming Investor Conferences

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

View all latest news

Twist Bioscience Corporation

Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States